Tirzepatide vs Semaglutide: How to Choose

If you're looking at a GLP-1 program, you'll run into two names constantly: semaglutide and tirzepatide. They're related but not identical, and programs sometimes specialize in one or the other. This is a plain-English guide to the difference — but the actual decision belongs with a licensed clinician who knows your history.

What they are

Semaglutide is a GLP-1 receptor agonist — it mimics a gut hormone that helps regulate appetite and blood sugar. It's the active ingredient in several well-known branded weight-loss and diabetes medications. Tirzepatide acts on GLP-1 and a second receptor (GIP), which is why it's sometimes described as a "dual" agonist. Both are given as weekly injections and both are titrated up gradually.

How they differ in practice

The headline difference is mechanism — tirzepatide's dual action versus semaglutide's single pathway. In practice, the factors that tend to decide the choice are more mundane: how your body tolerates each, side-effect profile, availability and cost of the specific product, and your clinician's judgment about your health profile. Neither is universally "better"; they're tools matched to a person.

Practical factors that decide it

• Tolerability. Some people handle one better than the other. Side effects and how gently you can titrate matter a lot.
• Availability and cost. Supply and price for a specific product shift over time and can steer the decision.
• Your health profile. Existing conditions and medications can make one option more appropriate.
• Program specialization. Some programs are built around one medication — TrimRx, for instance, focuses on tirzepatide.

This article is general educational information and not medical advice. It does not compare efficacy or safety and should not be used to self-select a medication. Talk to a licensed clinician.